Chemomab Therapeutics Ltd DRC (CMMB) — Working Capital to Net Assets Ratio
Chemomab Therapeutics Ltd DRC (CMMB) has a Working Capital to Net Assets ratio of 96.9% as of December 2025. Working capital of $11.95 Million (current assets of $13.42 Million minus current liabilities of $1.48 Million) is measured against net assets of $12.33 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how financially flexible is Chemomab Therapeutics Ltd DRC to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Chemomab Therapeutics Ltd DRC Working Capital to Net Assets (2012–2025)
This chart shows how Chemomab Therapeutics Ltd DRC's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 96.9%, reflecting working capital of $11.95 Million against net assets of $12.33 Million USD. See Chemomab Therapeutics Ltd DRC (CMMB) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Chemomab Therapeutics Ltd DRC (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Chemomab Therapeutics Ltd DRC from 2012 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Chemomab Therapeutics Ltd DRC market cap and net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 96.9% | $11.95 Million | $12.33 Million | $13.42 Million | $1.48 Million | ▲ +2.1 pp |
| 2024 | 94.7% | $12.82 Million | $13.54 Million | $16.04 Million | $3.22 Million | ▲ +0.2 pp |
| 2023 | 94.5% | $16.06 Million | $17.00 Million | $20.90 Million | $4.84 Million | ▼ -2.1 pp |
| 2022 | 96.6% | $34.99 Million | $36.22 Million | $41.74 Million | $6.75 Million | ▼ -1.1 pp |
| 2021 | 97.7% | $60.04 Million | $61.47 Million | $62.69 Million | $2.65 Million | ▲ +0.3 pp |
| 2020 | 97.4% | $10.52 Million | $10.80 Million | $11.84 Million | $1.32 Million | ▲ +2.9 pp |
| 2019 | 94.5% | $14.09 Million | $14.91 Million | $18.21 Million | $4.12 Million | ▲ +11.1 pp |
| 2018 | 83.4% | $8.17 Million | $9.80 Million | $10.92 Million | $2.75 Million | ▼ -98.4 pp |
| 2017 | 181.8% | $-1.11 Million | $-609.00K | $1.59 Million | $2.70 Million | ▲ +105.5 pp |
| 2016 | 76.3% | $2.51 Million | $3.29 Million | $4.87 Million | $2.36 Million | ▼ -6.0 pp |
| 2015 | 82.3% | $1.76 Million | $2.14 Million | $3.10 Million | $1.33 Million | ▼ -47.4 pp |
| 2012 | 129.7% | $4.27 Million | $3.29 Million | $9.16 Million | $4.89 Million | — |